These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 22923341

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trial.
    Brignole M, Botto G, Mont L, Iacopino S, De Marchi G, Oddone D, Luzi M, Tolosana JM, Navazio A, Menozzi C.
    Eur Heart J; 2011 Oct; 32(19):2420-9. PubMed ID: 21606084
    [Abstract] [Full Text] [Related]

  • 5. Assessment of upgrading to biventricular pacing in patients with right ventricular pacing and congestive heart failure after atrioventricular junctional ablation for chronic atrial fibrillation.
    Valls-Bertault V, Fatemi M, Gilard M, Pennec PY, Etienne Y, Blanc JJ.
    Europace; 2004 Sep; 6(5):438-43. PubMed ID: 15294269
    [Abstract] [Full Text] [Related]

  • 6. Right atrial pacing and the risk of postimplant atrial fibrillation in cardiac resynchronization therapy recipients.
    Adelstein E, Saba S.
    Am Heart J; 2008 Jan; 155(1):94-9. PubMed ID: 18082497
    [Abstract] [Full Text] [Related]

  • 7. Long-term retention of cardiac resynchronization therapy.
    Knight BP, Desai A, Coman J, Faddis M, Yong P.
    J Am Coll Cardiol; 2004 Jul 07; 44(1):72-7. PubMed ID: 15234410
    [Abstract] [Full Text] [Related]

  • 8. Incidence and clinical relevance of uncontrolled ventricular rate during atrial fibrillation in heart failure patients treated with cardiac resynchronization therapy.
    Boriani G, Gasparini M, Landolina M, Lunati M, Proclemer A, Lonardi G, Iacopino S, Rahue W, Biffi M, DiStefano P, Grammatico A, Santini M, ClinicalService cardiac centres.
    Eur J Heart Fail; 2011 Aug 07; 13(8):868-76. PubMed ID: 21558331
    [Abstract] [Full Text] [Related]

  • 9. Dynamic ventricular overdrive stimulation in atrial fibrillation: effects on ventricular rate irregularity, ventricular pacing, and fusion beats.
    Nölker G, Gutleben KJ, Asbach S, Ritscher G, Marschang H, Sinha AM, Boileau P, Benser ME, Hallier B, Hümmer A, Brachmann J.
    Europace; 2011 Dec 07; 13(12):1688-94. PubMed ID: 21784744
    [Abstract] [Full Text] [Related]

  • 10. Reduction of RV pacing by continuous optimization of the AV interval.
    Milasinovic G, Sperzel J, Smith TW, Mead H, Brandt J, Haisty WK, Bailey JR, Roelke M, Simonson J, Gerritse B, Englund J, Compton SJ, Worldwide EnPulse Investigators.
    Pacing Clin Electrophysiol; 2006 Apr 07; 29(4):406-12. PubMed ID: 16650270
    [Abstract] [Full Text] [Related]

  • 11. Continuous optimization of cardiac resynchronization therapy reduces atrial fibrillation in heart failure patients: Results of the Adaptive Cardiac Resynchronization Therapy Trial.
    Birnie D, Hudnall H, Lemke B, Aonuma K, Lee KL, Gasparini M, Gorcsan J, Cerkvenik J, Martin DO.
    Heart Rhythm; 2017 Dec 07; 14(12):1820-1825. PubMed ID: 28893549
    [Abstract] [Full Text] [Related]

  • 12. A novel algorithm increases the delivery of effective cardiac resynchronization therapy during atrial fibrillation: The CRTee randomized crossover trial.
    Plummer CJ, Frank CM, Bári Z, Al Hebaishi YS, Klepfer RN, Stadler RW, Ghosh S, Liu S, Mittal S.
    Heart Rhythm; 2018 Mar 07; 15(3):369-375. PubMed ID: 29132930
    [Abstract] [Full Text] [Related]

  • 13. Increase of ventricular interval during atrial fibrillation by atrioventricular node vagal stimulation: chronic clinical atrioventricular-nodal stimulation download study.
    Bianchi S, Rossi P, Schauerte P, Elvan A, Blomström-Lundqvist C, Kornet L, Gal P, Mörtsell D, Wouters G, Gemein C.
    Circ Arrhythm Electrophysiol; 2015 Jun 07; 8(3):562-8. PubMed ID: 25878323
    [Abstract] [Full Text] [Related]

  • 14. Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial.
    Padeletti L, Muto C, Maounis T, Schuchert A, Bongiorni MG, Frank R, Vesterlund T, Brachmann J, Vicentini A, Jauvert G, Tadeo G, Gras D, Lisi F, Dello Russo A, Rey JL, Boulogne E, Ricciardi G, Management of Atrial fibrillation Suppression in AF-HF COmorbidity Therapy Study Group.
    Am Heart J; 2008 Sep 07; 156(3):520-6. PubMed ID: 18760135
    [Abstract] [Full Text] [Related]

  • 15. Optimal sensed atrio-ventricular interval determined by paced QRS morphology.
    Van Gelder BM, Bracke FA, Van Der Voort PH, Meijer A.
    Pacing Clin Electrophysiol; 2007 Apr 07; 30(4):476-81. PubMed ID: 17437570
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The importance of increased percentage of biventricular pacing to improve clinical outcomes in patients receiving cardiac resynchronization therapy.
    Gasparini M, Galimberti P, Ceriotti C.
    Curr Opin Cardiol; 2013 Jan 07; 28(1):50-4. PubMed ID: 23196776
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.